Stefania Giuliano

Catanzaro, 88100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer.

Insulin resistance and metabolic dysfunction in thyroid nodules and differentiated thyroid cancer.

Journal: Current opinion in oncology

Published: November 12, 2025

Gestational Diabetes Risk May Vary Depending on Birth Month.

Gestational Diabetes Risk May Vary Depending on Birth Month.

Journal: Journal of clinical medicine

Published: October 03, 2025

Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional Study.

Circulating Thrombospondin-1 and Endothelin-1 Levels Tend to Decline with Increasing Obesity Severity in Women: Evidence from a Pilot, Cross-Sectional Study.

Journal: Journal of clinical medicine

Published: January 29, 2025

Clinical Risk Factors and First Gestational 75 g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous Women.

Clinical Risk Factors and First Gestational 75 g OGTT May Predict Recurrent and New-Onset Gestational Diabetes in Multiparous Women.

Journal: Journal of clinical medicine

Published: July 25, 2024

Coexistence of Hashimoto's Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response.

Coexistence of Hashimoto's Thyroiditis in Differentiated Thyroid Cancer: Post-Operative Monitoring of Anti-Thyroglobulin Antibodies and Assessment of Treatment Response.

Journal: Diagnostics (Basel, Switzerland)

Published: November 30, 2023

Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common finding.

Incidental thyroid carcinoma in an endemic goiter area in Italy: histopathological features and predictors of a common finding.

Journal: Endocrine

Published: September 13, 2023

Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question.

Metformin in Gestational Diabetes Mellitus: To Use or Not to Use, That Is the Question.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 01, 2023

Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus.

Maternal Preconception Body Mass Index Overtakes Age as a Risk Factor for Gestational Diabetes Mellitus.

Journal: Journal of clinical medicine

Published: March 20, 2023

Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot study.

Predicting the response to SGLT-2 inhibitors as add-on therapy to multiple day injection insulin with glycated albumin: a pilot study.

Journal: Minerva endocrinology

Published: February 01, 2022

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.

Clinical Effectiveness and Safety of Once-Weekly GLP-1 Receptor Agonist Dulaglutide as Add-On to Metformin or Metformin Plus Insulin Secretagogues in Obesity and Type 2 Diabetes.

Journal: Journal of clinical medicine

Published: January 12, 2021

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes.

Long-Term Effectiveness of Liraglutide for Weight Management and Glycemic Control in Type 2 Diabetes.

Journal: International journal of environmental research and public health

Published: November 27, 2019

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.

Journal: Frontiers in endocrinology

Published: November 23, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026